Related Experiment Video
Updated: Jun 30, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms
Runhua Liu1, Lizhong Wang, Chong Chen
1Department of Surgery, Division of Immunotherapy, Program of Molecular Mechanism of Diseases andComprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, USA.
Abstract:
Glycogen synthase kinase 3beta (GSK-3beta) represses cell cycle progression by directly phosphorylating cyclin D1 and indirectly regulating cyclin D1 transcription by inhibiting Wnt signaling. Recently, we reported that the Epm2a-encoded laforin is a GSK-3beta phosphatase and a tumor suppressor. The cellular mechanism for its tumor suppression remains unknown. Using ex vivo thymocytes and primary embryonic fibroblasts from Epm2a(-/-) mice, we show here a general function of laforin in the cell cycle regulation and repression of cyclin D1 expression. Moreover, targeted mutation of Epm2a increased the phosphorylation of Ser9 on GSK-3beta while having no effect on the phosphorylation of Ser21 on GSK-3alpha. In the GSK-3beta(+/+) but not the GSK-3beta(-/-) cells, Epm2a small interfering RNA significantly enhanced cell growth. Consistent with an increased level of cyclin D1, the phosphorylation of retinoblastoma protein (Rb) and the levels of Rb-E2F-regulated genes cyclin A, cyclin E, MCM3, and PCNA are also elevated. Inhibitors of GSK-3beta selectively increased the cell growth of Epm2a(+/+) but not of Epm2a(-/-) cells. Taken together, our data demonstrate that laforin is a selective phosphatase for GSK-3beta and regulates cell cycle progression by GSK-3beta-dependent mechanisms. These data provide a cellular basis for the tumor suppression activity of laforin.
Insights
Laforin, a phosphatase for Glycogen synthase kinase 3beta (GSK-3beta), suppresses tumor growth by regulating cell cycle progression and cyclin D1 expression through GSK-3beta-dependent mechanisms.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Glycogen synthase kinase 3beta (GSK-3beta) inhibits cell cycle progression by phosphorylating cyclin D1 and Wnt signaling.
- Laforin, encoded by Epm2a, is a GSK-3beta phosphatase and a known tumor suppressor.
- The precise cellular mechanism underlying laforin's tumor suppressive activity is not fully understood.
Purpose of the Study:
- To elucidate the cellular mechanism of laforin's tumor suppression.
- To investigate laforin's role in cell cycle regulation and cyclin D1 expression.
- To determine if laforin acts as a selective phosphatase for GSK-3beta.
Main Methods:
- Utilized ex vivo thymocytes and primary embryonic fibroblasts from Epm2a(-/-) mice.
- Employed small interfering RNA (siRNA) against Epm2a in GSK-3beta(+/+) and GSK-3beta(-/-) cells.
- Administered GSK-3beta inhibitors to Epm2a(+/+) and Epm2a(-/-) cells.
Main Results:
- Laforin deficiency in mice led to increased GSK-3beta phosphorylation at Ser9, without affecting GSK-3alpha.
- Epm2a knockdown in GSK-3beta(+/+) cells enhanced cell growth and increased cyclin D1, phosphorylated retinoblastoma protein (Rb), and Rb-E2F-regulated genes.
- GSK-3beta inhibitors selectively promoted the growth of Epm2a(+/+) cells, but not Epm2a(-/-) cells.
Conclusions:
- Laforin functions as a selective phosphatase for GSK-3beta.
- Laforin regulates cell cycle progression via GSK-3beta-dependent pathways.
- These findings provide a cellular basis for laforin's tumor suppressor activity.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules
Positive Regulator Molecules

